Recent Security Class Actions

ImmunityBio Inc. Common Stock (NASDAQ: IBRX)

23 Days left to seek lead plaintiff status.

Company Name:ImmunityBio Inc. Common Stock
Stock Symbol:NASDAQ: IBRX
Class Period Start:01/19/2026
Class Period End (inclusive):03/24/2026
Filing Deadline:05/25/2026

The Complaint alleges that Defendants' statements were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva’s capabilities; and (2) as a result, Defendants’ statements about ImmunityBio’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

ImmunityBio Inc. Common Stock (NASDAQ: IBRX) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address